Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 91 entries
Sorted by: Best Match Show Resources per page
AuthorBase: a database of authoring systems software.

Proceedings. Symposium on Computer Applications in Medical Care

Lo R, Locatis C, Ullmer E, Carr V, Banvard R, Le Q, Williamson M, Ackerman M.
PMID: 1807735
Proc Annu Symp Comput Appl Med Care. 1991;875-6.
Free PMC Article

A working prototype database of authoring system software was developed as part of a study of authoring software conducted by the National Library of Medicine. The database and development issues ranging from the scope of the database to what...

Cite
Lo R, Locatis C, Ullmer E, et al. AuthorBase: a database of authoring systems software. Proc Annu Symp Comput Appl Med Care. 1991;875-6
Lo, R., Locatis, C., Ullmer, E., Carr, V., Banvard, R., Le, Q., Williamson, M., & Ackerman, M. (1991). AuthorBase: a database of authoring systems software. Proceedings. Symposium on Computer Applications in Medical Care, 875-6.
Lo, R, et al. "AuthorBase: a database of authoring systems software." Proceedings. Symposium on Computer Applications in Medical Care vol. (1991): 875-6.
Lo R, Locatis C, Ullmer E, Carr V, Banvard R, Le Q, Williamson M, Ackerman M. AuthorBase: a database of authoring systems software. Proc Annu Symp Comput Appl Med Care. 1991;875-6. PMID: 1807735; PMCID: PMC2247658.
Copy Download .nbib Format: NLM
Clinical Relevance Of Systematic CRT Device Optimization.

Journal of atrial fibrillation

Lunati M, Magenta G, Cattafi G, Moreo A, Falaschi G, Contardi D, Locati E.
PMID: 27957096
J Atr Fibrillation. 2014 Aug 31;7(2):1077. doi: 10.4022/jafib.1077. eCollection 2014.

Cardiac Resynchronization Therapy (CRT) is known as a highly effective therapy in advanced heart failure patients with cardiac dyssynchrony. However, still one third of patients do not respond (or sub-optimally respond) to CRT. Among the many contributors for the...

Cite
Lunati M, Magenta G, Cattafi G, et al. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014;7(2):1077doi: 10.4022/jafib.1077.
Lunati, M., Magenta, G., Cattafi, G., Moreo, A., Falaschi, G., Contardi, D., & Locati, E. (2014). Clinical Relevance Of Systematic CRT Device Optimization. Journal of atrial fibrillation, 7(2), 1077. https://doi.org/10.4022/jafib.1077
Lunati, Maurizio, et al. "Clinical Relevance Of Systematic CRT Device Optimization." Journal of atrial fibrillation vol. 7,2 (2014): 1077. doi: https://doi.org/10.4022/jafib.1077
Lunati M, Magenta G, Cattafi G, Moreo A, Falaschi G, Contardi D, Locati E. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014 Aug 31;7(2):1077. doi: 10.4022/jafib.1077. eCollection 2014. PMID: 27957096; PMCID: PMC5135253.
Copy Download .nbib Format: NLM
Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness.

Oncoimmunology

Bonecchi R, Savino B, Caronni N, Celesti G, Mantovani A, Locati M.
PMID: 25964861
Oncoimmunology. 2015 Jan 07;3(12):e955337. doi: 10.4161/21624011.2014.955337. eCollection 2014 Dec.

Inflammatory chemokines are instrumental players in cancer-related inflammation contributing to numerous steps during tumor progression. In Kaposi's sarcoma, we have found that downregulation of the atypical chemokine receptor 2 (ACKR2) by the KRAS/BRAF/ERK pathway profoundly affects the tumor microenvironment,...

Cite
Bonecchi R, Savino B, Caronni N, et al. Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness. Oncoimmunology. 2015;3(12):e955337doi: 10.4161/21624011.2014.955337.
Bonecchi, R., Savino, B., Caronni, N., Celesti, G., Mantovani, A., & Locati, M. (2014). Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness. Oncoimmunology, 3(12), e955337. https://doi.org/10.4161/21624011.2014.955337
Bonecchi, Raffaella, et al. "Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness." Oncoimmunology vol. 3,12 (2014): e955337. doi: https://doi.org/10.4161/21624011.2014.955337
Bonecchi R, Savino B, Caronni N, Celesti G, Mantovani A, Locati M. Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness. Oncoimmunology. 2015 Jan 07;3(12):e955337. doi: 10.4161/21624011.2014.955337. eCollection 2014 Dec. PMID: 25964861; PMCID: PMC4353167.
Copy Download .nbib Format: NLM
Allosteric Modulation of Chemoattractant Receptors.

Frontiers in immunology

Allegretti M, Cesta MC, Locati M.
PMID: 27199992
Front Immunol. 2016 May 02;7:170. doi: 10.3389/fimmu.2016.00170. eCollection 2016.

Chemoattractants control selective leukocyte homing via interactions with a dedicated family of related G protein-coupled receptor (GPCR). Emerging evidence indicates that the signaling activity of these receptors, as for other GPCR, is influenced by allosteric modulators, which interact with...

Cite
Allegretti M, Cesta MC, Locati M. Allosteric Modulation of Chemoattractant Receptors. Front Immunol. 2016;7:170doi: 10.3389/fimmu.2016.00170.
Allegretti, M., Cesta, M. C., & Locati, M. (2016). Allosteric Modulation of Chemoattractant Receptors. Frontiers in immunology, 7170. https://doi.org/10.3389/fimmu.2016.00170
Allegretti, Marcello, et al. "Allosteric Modulation of Chemoattractant Receptors." Frontiers in immunology vol. 7 (2016): 170. doi: https://doi.org/10.3389/fimmu.2016.00170
Allegretti M, Cesta MC, Locati M. Allosteric Modulation of Chemoattractant Receptors. Front Immunol. 2016 May 02;7:170. doi: 10.3389/fimmu.2016.00170. eCollection 2016. PMID: 27199992; PMCID: PMC4852175.
Copy Download .nbib Format: NLM
Extending a Blended Education Program to Native American High School Students in Alaska.

Journal of visual communication in medicine

Locatis C, Gaines C, Liu WL, Gill M.
PMID: 21494418
J Vis Commun Med. 2009 Jan;32(1):8-13. doi: 10.1080/17453050902821181.

This article describes the expansion of a blended learning program sponsored by the National Library of Medicine (NLM) that combines synchronous distance learning with face to face instruction. Background information about the program is briefly discussed and challenges to...

Cite
Locatis C, Gaines C, Liu WL, et al. Extending a Blended Education Program to Native American High School Students in Alaska. J Vis Commun Med. 2009;32(1):8-13doi: 10.1080/17453050902821181.
Locatis, C., Gaines, C., Liu, W. L., & Gill, M. (2009). Extending a Blended Education Program to Native American High School Students in Alaska. Journal of visual communication in medicine, 32(1), 8-13. https://doi.org/10.1080/17453050902821181
Locatis, Craig, et al. "Extending a Blended Education Program to Native American High School Students in Alaska." Journal of visual communication in medicine vol. 32,1 (2009): 8-13. doi: https://doi.org/10.1080/17453050902821181
Locatis C, Gaines C, Liu WL, Gill M. Extending a Blended Education Program to Native American High School Students in Alaska. J Vis Commun Med. 2009 Jan;32(1):8-13. doi: 10.1080/17453050902821181. PMID: 21494418; PMCID: PMC3074495.
Copy Download .nbib Format: NLM
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM.

Vaccines

Scala S, D'Alterio C, Milanesi S, Castagna A, Carriero R, Farina FM, Locati M, Borroni EM.
PMID: 32260318
Vaccines (Basel). 2020 Apr 03;8(2). doi: 10.3390/vaccines8020164.

Deciphering the molecular alterations leading to disease initiation and progression is currently crucial to identify the most relevant targets for precision therapy in cancer patients. Cancers express a complex chemokine network influencing leucocyte infiltration and angiogenesis. Moreover, malignant cells...

Cite
Scala S, D'Alterio C, Milanesi S, et al. New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines (Basel). 2020;8(2)doi: 10.3390/vaccines8020164.
Scala, S., D'Alterio, C., Milanesi, S., Castagna, A., Carriero, R., Farina, F. M., Locati, M., & Borroni, E. M. (2020). New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines, 8(2), . https://doi.org/10.3390/vaccines8020164
Scala, Stefania, et al. "New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM." Vaccines vol. 8,2 (2020). doi: https://doi.org/10.3390/vaccines8020164
Scala S, D'Alterio C, Milanesi S, Castagna A, Carriero R, Farina FM, Locati M, Borroni EM. New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines (Basel). 2020 Apr 03;8(2). doi: 10.3390/vaccines8020164. PMID: 32260318; PMCID: PMC7349554.
Copy Download .nbib Format: NLM
Dermatomyositis- Related Intestinal Dysmotility.

Modern rheumatology case reports

Loftis C, White R, Dulgheru EC.
PMID: 34791372
Mod Rheumatol Case Rep. 2021 Nov 17; doi: 10.1093/mrcr/rxab043. Epub 2021 Nov 17.

Dermatomyositis (DM) is an inflammatory myopathy characterized by proximal muscle weakness and pathognomonic skin lesions. A 69-year-old woman with a recent diagnosis of DM one month prior, treated with corticosteroids and immunomodulators, presented to our inpatient rehabilitation with worsening...

Cite
Loftis C, White R, Dulgheru EC. Dermatomyositis- Related Intestinal Dysmotility. Mod Rheumatol Case Rep. 2021;doi: 10.1093/mrcr/rxab043.
Loftis, C., White, R., & Dulgheru, E. C. (2021). Dermatomyositis- Related Intestinal Dysmotility. Modern rheumatology case reports, . https://doi.org/10.1093/mrcr/rxab043
Loftis, Christine, et al. "Dermatomyositis- Related Intestinal Dysmotility." Modern rheumatology case reports vol. (2021). doi: https://doi.org/10.1093/mrcr/rxab043
Loftis C, White R, Dulgheru EC. Dermatomyositis- Related Intestinal Dysmotility. Mod Rheumatol Case Rep. 2021 Nov 17; doi: 10.1093/mrcr/rxab043. Epub 2021 Nov 17. PMID: 34791372.
Copy Download .nbib Format: NLM
Please mind the gap-about equity and access to care in oncology.

ESMO open

Barcellini A, Dal Mas F, Paoloni P, Loap P, Cobianchi L, Locati L, Rodríguez-Luna MR, Orlandi E.
PMID: 34902710
ESMO Open. 2021 Dec 10;6(6):100335. doi: 10.1016/j.esmoop.2021.100335. Epub 2021 Dec 10.

No abstract available.

Cite
Barcellini A, Dal Mas F, Paoloni P, et al. Please mind the gap-about equity and access to care in oncology. ESMO Open. 2021;6(6):100335doi: 10.1016/j.esmoop.2021.100335.
Barcellini, A., Dal Mas, F., Paoloni, P., Loap, P., Cobianchi, L., Locati, L., Rodríguez-Luna, M. R., & Orlandi, E. (2021). Please mind the gap-about equity and access to care in oncology. ESMO open, 6(6), 100335. https://doi.org/10.1016/j.esmoop.2021.100335
Barcellini, A, et al. "Please mind the gap-about equity and access to care in oncology." ESMO open vol. 6,6 (2021): 100335. doi: https://doi.org/10.1016/j.esmoop.2021.100335
Barcellini A, Dal Mas F, Paoloni P, Loap P, Cobianchi L, Locati L, Rodríguez-Luna MR, Orlandi E. Please mind the gap-about equity and access to care in oncology. ESMO Open. 2021 Dec 10;6(6):100335. doi: 10.1016/j.esmoop.2021.100335. Epub 2021 Dec 10. PMID: 34902710.
Copy Download .nbib Format: NLM
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Pepe G, Sfogliarini C, Rizzello L, Battaglia G, Pinna C, Rovati G, Ciana P, Brunialti E, Mornata F, Maggi A, Locati M, Vegeto E.
PMID: 34653752
Biomed Pharmacother. 2021 Dec;144:112274. doi: 10.1016/j.biopha.2021.112274. Epub 2021 Oct 12.

Sex differences in immune-mediated diseases are linked to the activity of estrogens on innate immunity cells, including macrophages. Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) used in estrogen receptor-alpha (ERα)-dependent breast cancers and off-target indications such as...

Cite
Pepe G, Sfogliarini C, Rizzello L, et al. ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen. Biomed Pharmacother. 2021;144:112274doi: 10.1016/j.biopha.2021.112274.
Pepe, G., Sfogliarini, C., Rizzello, L., Battaglia, G., Pinna, C., Rovati, G., Ciana, P., Brunialti, E., Mornata, F., Maggi, A., Locati, M., & Vegeto, E. (2021). ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 144112274. https://doi.org/10.1016/j.biopha.2021.112274
Pepe, Giovanna, et al. "ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 144 (2021): 112274. doi: https://doi.org/10.1016/j.biopha.2021.112274
Pepe G, Sfogliarini C, Rizzello L, Battaglia G, Pinna C, Rovati G, Ciana P, Brunialti E, Mornata F, Maggi A, Locati M, Vegeto E. ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen. Biomed Pharmacother. 2021 Dec;144:112274. doi: 10.1016/j.biopha.2021.112274. Epub 2021 Oct 12. PMID: 34653752.
Copy Download .nbib Format: NLM
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.

European urology focus

Lonati C, Baumeister P, Afferi L, Mari A, Minervini A, Krajewski W, Azizi S, Hendricksen K, Martini A, Necchi A, Montorsi F, Briganti A, Colombo R, Tafuri A, Antonelli A, Cerruto MA, Rouprêt M, Masson-Lecomte A, Laukhtina E, D'Andrea D, Shariat SF, Soria F, Marra G, Gontero P, Contieri R, Hurle R, Valiquette AS, Mir MC, Zamboni S, Simeone C, Klatte T, Teoh JY, Yoshida S, Fujii Y, Carando R, Schulz GB, Mordasini L, Mattei A, Moschini M.
PMID: 34419381
Eur Urol Focus. 2021 Aug 18; doi: 10.1016/j.euf.2021.07.015. Epub 2021 Aug 18.

BACKGROUND: Literature lacks clear evidence regarding the optimal treatment for non-muscle-invasive micropapillary bladder cancer (MPBC) due to its rarity and the presence of only small sample size and single-centre studies.OBJECTIVE: To assess cancer-specific mortality (CSM) and overall mortality (OM)...

Cite
Lonati C, Baumeister P, Afferi L, et al. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021;doi: 10.1016/j.euf.2021.07.015.
Lonati, C., Baumeister, P., Afferi, L., Mari, A., Minervini, A., Krajewski, W., Azizi, S., Hendricksen, K., Martini, A., Necchi, A., Montorsi, F., Briganti, A., Colombo, R., Tafuri, A., Antonelli, A., Cerruto, M. A., Rouprêt, M., Masson-Lecomte, A., Laukhtina, E., D'Andrea, D., Shariat, S. F., Soria, F., Marra, G., Gontero, P., Contieri, R., Hurle, R., Valiquette, A. S., Mir, M. C., Zamboni, S., Simeone, C., Klatte, T., Teoh, J. Y., Yoshida, S., Fujii, Y., Carando, R., Schulz, G. B., Mordasini, L., Mattei, A., Moschini, M. (2021). Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. European urology focus, . https://doi.org/10.1016/j.euf.2021.07.015
Lonati, Chiara, et al. "Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration." European urology focus vol. (2021). doi: https://doi.org/10.1016/j.euf.2021.07.015
Lonati C, Baumeister P, Afferi L, Mari A, Minervini A, Krajewski W, Azizi S, Hendricksen K, Martini A, Necchi A, Montorsi F, Briganti A, Colombo R, Tafuri A, Antonelli A, Cerruto MA, Rouprêt M, Masson-Lecomte A, Laukhtina E, D'Andrea D, Shariat SF, Soria F, Marra G, Gontero P, Contieri R, Hurle R, Valiquette AS, Mir MC, Zamboni S, Simeone C, Klatte T, Teoh JY, Yoshida S, Fujii Y, Carando R, Schulz GB, Mordasini L, Mattei A, Moschini M. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021 Aug 18; doi: 10.1016/j.euf.2021.07.015. Epub 2021 Aug 18. PMID: 34419381.
Copy Download .nbib Format: NLM
The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis.

Journal of clinical medicine

Nowak Ł, Krajewski W, Chorbińska J, Kiełb P, Sut M, Moschini M, Teoh JY, Mori K, Del Giudice F, Laukhtina E, Lonati C, Kaliszewski K, Małkiewicz B, Szydełko T.
PMID: 34575307
J Clin Med. 2021 Sep 16;10(18). doi: 10.3390/jcm10184197.

BACKGROUND: The incidence of intravesical recurrence (IVR) following radical nephroureterectomy (RNU) is reported in up to 50% of patients with upper tract urothelial carcinoma (UTUC). It was suggested that preoperative diagnostic ureteroscopy (URS) could increase the IVR rate after...

Cite
Nowak Ł, Krajewski W, Chorbińska J, et al. The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis. J Clin Med. 2021;10(18)doi: 10.3390/jcm10184197.
Nowak, �. �., Krajewski, W., Chorbińska, J., Kiełb, P., Sut, M., Moschini, M., Teoh, J. Y., Mori, K., Del Giudice, F., Laukhtina, E., Lonati, C., Kaliszewski, K., Małkiewicz, B., & Szydełko, T. (2021). The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis. Journal of clinical medicine, 10(18), . https://doi.org/10.3390/jcm10184197
Nowak, Łukasz, et al. "The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis." Journal of clinical medicine vol. 10,18 (2021). doi: https://doi.org/10.3390/jcm10184197
Nowak Ł, Krajewski W, Chorbińska J, Kiełb P, Sut M, Moschini M, Teoh JY, Mori K, Del Giudice F, Laukhtina E, Lonati C, Kaliszewski K, Małkiewicz B, Szydełko T. The Impact of Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma: A Comprehensive Systematic Review and Meta-Analysis. J Clin Med. 2021 Sep 16;10(18). doi: 10.3390/jcm10184197. PMID: 34575307; PMCID: PMC8465597.
Copy Download .nbib Format: NLM
The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and Evolution.

Bioscience

Heger T, Aguilar-Trigueros CA, Bartram I, Braga RR, Dietl GP, Enders M, Gibson DJ, Gómez-Aparicio L, Gras P, Jax K, Lokatis S, Lortie CJ, Mupepele AC, Schindler S, Starrfelt J, Synodinos AD, Jeschke JM.
PMID: 33867867
Bioscience. 2020 Dec 02;71(4):337-349. doi: 10.1093/biosci/biaa130. eCollection 2021 Apr.

In the current era of Big Data, existing synthesis tools such as formal meta-analyses are critical means to handle the deluge of information. However, there is a need for complementary tools that help to (a) organize evidence, (b) organize...

Cite
Heger T, Aguilar-Trigueros CA, Bartram I, et al. The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and Evolution. Bioscience. 2020;71(4):337-349doi: 10.1093/biosci/biaa130.
Heger, T., Aguilar-Trigueros, C. A., Bartram, I., Braga, R. R., Dietl, G. P., Enders, M., Gibson, D. J., Gómez-Aparicio, L., Gras, P., Jax, K., Lokatis, S., Lortie, C. J., Mupepele, A. C., Schindler, S., Starrfelt, J., Synodinos, A. D., & Jeschke, J. M. (2021). The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and Evolution. Bioscience, 71(4), 337-349. https://doi.org/10.1093/biosci/biaa130
Heger, Tina, et al. "The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and Evolution." Bioscience vol. 71,4 (2021): 337-349. doi: https://doi.org/10.1093/biosci/biaa130
Heger T, Aguilar-Trigueros CA, Bartram I, Braga RR, Dietl GP, Enders M, Gibson DJ, Gómez-Aparicio L, Gras P, Jax K, Lokatis S, Lortie CJ, Mupepele AC, Schindler S, Starrfelt J, Synodinos AD, Jeschke JM. The Hierarchy-of-Hypotheses Approach: A Synthesis Method for Enhancing Theory Development in Ecology and Evolution. Bioscience. 2020 Dec 02;71(4):337-349. doi: 10.1093/biosci/biaa130. eCollection 2021 Apr. PMID: 33867867; PMCID: PMC8038874.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 91 entries